ERBB2 and invasive ductal breast carcinoma: Median age at diagnosis was 61 years (IQR 52–69), and the majority (80%) of patients (Table 1) were non-comorbid and diagnosed with invasive ductal carcinoma of the breast with ER+/HER2-negative status (56%).